IGC Pharma, Inc. financial data

Symbol
IGC on NYSE
Industry
Pharmaceutical Preparations
Location
10224 Falls Road, Potomac, MD
State of incorporation
MD
Fiscal year end
March 31
Former names
India Globalization Capital, Inc. (to 3/21/2023)
Latest financial report
10-Q - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 150 % -43.1%
Quick Ratio 58.3 % -52.3%
Debt-to-equity 38.5 % +111%
Return On Assets -88.2 % +5.5%
Operating Margin -664 % +30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 79.7M shares +25%
Common Stock, Shares, Outstanding 78.2M shares +22.7%
Entity Public Float 20.9M USD +0.34%
Weighted Average Number of Shares Outstanding, Basic 77.6M shares +21.8%
Weighted Average Number of Shares Outstanding, Diluted 77.6M shares +21.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.24M USD +1.73%
Cost of Revenue 600K USD +1.7%
Research and Development Expense 3.51M USD +2.99%
Operating Income (Loss) -8.2M USD +29.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.81M USD +37.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.81M USD +37.7%
Earnings Per Share, Basic -0.02 USD/shares +77.8%
Earnings Per Share, Diluted -0.02 USD/shares +77.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 470K USD -65.9%
Marketable Securities, Current 154K USD
Accounts Receivable, after Allowance for Credit Loss, Current 49K USD -46.7%
Inventory, Net 1.43M USD -25.6%
Other Assets, Current 304K USD +145%
Assets, Current 3.05M USD -14.8%
Property, Plant and Equipment, Net 3.35M USD -36.4%
Operating Lease, Right-of-Use Asset 129K USD -43.2%
Intangible Assets, Net (Excluding Goodwill) 1.87M USD +58.1%
Other Assets, Noncurrent 681K USD -31.8%
Assets 9.08M USD -19.4%
Accounts Payable, Current 835K USD +28.9%
Employee-related Liabilities, Current 864K USD +16%
Accrued Liabilities, Current 1.82M USD +41.5%
Liabilities, Current 2.66M USD +37.2%
Operating Lease, Liability, Noncurrent 12K USD -89.6%
Other Liabilities, Noncurrent 16K USD -5.88%
Liabilities 2.82M USD +27.8%
Common Stocks, Including Additional Paid in Capital 129M USD +4.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.46M USD -0.99%
Retained Earnings (Accumulated Deficit) -120M USD -7.95%
Stockholders' Equity Attributable to Parent 6.26M USD -30.9%
Liabilities and Equity 9.08M USD -19.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD -19.3%
Net Cash Provided by (Used in) Financing Activities 2.51M USD
Net Cash Provided by (Used in) Investing Activities -131K USD -2520%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 78.2M shares +22.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 626K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 470K USD -65.9%
Deferred Tax Assets, Valuation Allowance 15M USD +10.3%
Deferred Tax Assets, Gross 15M USD +10.3%
Operating Lease, Liability 208K USD -38.8%
Depreciation 577K USD +56.8%
Payments to Acquire Property, Plant, and Equipment 38K USD +90%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.84M USD +37.5%
Lessee, Operating Lease, Liability, to be Paid 340K USD -26.7%
Property, Plant and Equipment, Gross 5.95M USD -21.7%
Operating Lease, Liability, Current 124K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 132K USD -12.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -64.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 75K USD 0%
Depreciation, Depletion and Amortization 162K USD +4.52%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 402K USD +12.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%